Tabalumab (LY2127399) is a humanised monoclonal antibody targeting BAFF that neutralises both soluble and membrane-bound forms of BLyS and affects B-cell populations, and can be used for research into autoimmune diseases such as rheumatoid arthritis, kidney failure, and systemic lupus erythematosus.
Purity:
97.40%
CAS Number:
[1143503-67-6]
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted
